Cargando…

Polyglutamine diseases: looking beyond the neurodegenerative universe

Detalles Bibliográficos
Autores principales:	Mielcarek, Michal, Isalan, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224133/ https://www.ncbi.nlm.nih.gov/pubmed/33269768 http://dx.doi.org/10.4103/1673-5374.300434

Ejemplares similares

Neuro-Cardio Mechanisms in Huntington’s Disease and Other Neurodegenerative Disorders
por: Critchley, Bethan J., et al.
Publicado: (2018)

Molecular Origin of Polyglutamine Aggregation in Neurodegenerative Diseases
por: Khare, Sagar D, et al.
Publicado: (2005)

A shared mechanism of muscle wasting in cancer and Huntington’s disease
por: Mielcarek, Michal, et al.
Publicado: (2015)

Androgen receptor polyglutamine repeat number: models of selection and disease susceptibility
por: Ryan, Calen P, et al.
Publicado: (2013)

On the role of RNA binding proteins in polyglutamine diseases: from pathogenesis to therapeutics
por: Conceição, André, et al.
Publicado: (2023)

Kinetin stimulates differentiation of C2C12 myoblasts
por: Mielcarek, Michal, et al.
Publicado: (2021)

A minimal region of the HSP90AB1 promoter is suitable for ubiquitous expression in different somatic tissues with applicability for gene therapy
por: Mielcarek, Michal, et al.
Publicado: (2023)

Transcriptional Signature of an Altered Purine Metabolism in the Skeletal Muscle of a Huntington's Disease Mouse Model
por: Mielcarek, Michal, et al.
Publicado: (2017)

Beyond dentistry: could prevention and screening for neurodegenerative diseases start in the dental office?
por: Buccellato, Francesca R., et al.
Publicado: (2023)

Editorial: Neurodegenerative Diseases: Looking Beyond the Boundaries of the Brain
por: Gutiérrez-Ospina, Gabriel, et al.
Publicado: (2022)

Why It Is Time to Look Beyond Algal Genes in Photosynthetic Slugs
por: Rauch, Cessa, et al.
Publicado: (2015)

Early transcriptional alteration of histone deacetylases in a murine model of doxorubicin-induced cardiomyopathy
por: Piotrowska, Izabela, et al.
Publicado: (2017)

An Exploration of the Universe of Polyglutamine Structures
por: Gómez-Sicilia, Àngel, et al.
Publicado: (2015)

Looking beyond the hippocampus: old and new neurological targets for understanding memory disorders
por: Aggleton, John P.
Publicado: (2014)

Chaperones in Polyglutamine Aggregation: Beyond the Q-Stretch
por: Kuiper, E. F. E., et al.
Publicado: (2017)

The Aggregation Inhibitor Peptide QBP1 as a Therapeutic Molecule for the Polyglutamine Neurodegenerative Diseases
por: Popiel, H. Akiko, et al.
Publicado: (2011)

Quantitative connection between polyglutamine aggregation kinetics and neurodegenerative process in patients with Huntington’s disease
por: Sugaya, Keizo, et al.
Publicado: (2012)

Nuclear sphingomyelin in neurodegenerative diseases
por: Albi, Elisabetta, et al.
Publicado: (2021)

Gene Therapy Advances: A Meta-Analysis of AAV Usage in Clinical Settings
por: Au, Hau Kiu Edna, et al.
Publicado: (2022)

Microglia-targeting nanotherapeutics for neurodegenerative diseases
por: Zhao, Nanxia, et al.
Publicado: (2020)

Tayloring cell populations for neurodegenerative diseases
por: Fortin, Jeff M., et al.
Publicado: (2016)

Significance of intercellular communication for neurodegenerative diseases
por: Cihankaya, Hilal, et al.
Publicado: (2021)

Overcoming mitochondrial dysfunction in neurodegenerative diseases
por: Pessoa, João, et al.
Publicado: (2022)

Targeting mechanisms in cognitive training for neurodegenerative diseases
por: Venneri, Annalena, et al.
Publicado: (2020)

Impact of the metabolic syndrome on the evolution of neurodegenerative diseases
por: de A. Boleti, Ana Paula, et al.
Publicado: (2020)

Insights into the protective role of immunity in neurodegenerative disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

Protection against neurodegenerative disease on Earth and in space
por: Takamatsu, Yoshiki, et al.
Publicado: (2016)

Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
por: Jiang, Ziying, et al.
Publicado: (2022)

Therapeutic potential of lysosomal cathepsins for neurodegenerative diseases
por: Prieto Huarcaya, Susy, et al.
Publicado: (2022)

Enterovirus infection and its relationship with neurodegenerative diseases
por: Sousa, Ivanildo Pedro, et al.
Publicado: (2023)

Autophagy and polyglutamine diseases
por: Jimenez-Sanchez, Maria, et al.
Publicado: (2012)

Cross-Sectional Transcriptional Analysis of the Aging Murine Heart
por: Greenig, Matthew, et al.
Publicado: (2020)

Deimmunization for gene therapy: host matching of synthetic zinc finger constructs enables long-term mutant Huntingtin repression in mice
por: Agustín-Pavón, Carmen, et al.
Publicado: (2016)

Research-Based Intervention (RBI) for Autism Spectrum Disorder: Looking beyond Traditional Models and Outcome Measures for Clinical Trials
por: Narzisi, Antonio, et al.
Publicado: (2022)

Disease-associated oligodendrocyte signatures in neurodegenerative disease: the known and unknown
por: Schuster, Kristen H., et al.
Publicado: (2023)

Therapeutic induction of autophagy to modulate neurodegenerative disease progression
por: Hochfeld, Warren E, et al.
Publicado: (2013)

Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases
por: Vance, Jean E.
Publicado: (2012)

Role of myelin sheath energy metabolism in neurodegenerative diseases
por: Ravera, Silvia, et al.
Publicado: (2015)

Beneficial effects of date palm fruits on neurodegenerative diseases
por: Essa, Musthafa Mohamed, et al.
Publicado: (2016)

Tubulin glutamylation: a skeleton key for neurodegenerative diseases
por: van der Laan, Siem, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8njno0iqus6435gaiao6rf9ctk